2012
DOI: 10.1002/anie.201203193
|View full text |Cite
|
Sign up to set email alerts
|

Imageable Antigen‐Presenting Gold Nanoparticle Vaccines for Effective Cancer Immunotherapy In Vivo

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
65
0

Year Published

2013
2013
2016
2016

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 168 publications
(69 citation statements)
references
References 45 publications
4
65
0
Order By: Relevance
“…Studies demonstrated that nanoparticles, such as gold nanoparticles [15, 41, 42], silver nanoparticles [16], gelatin nanoparticles [43] and silica nanoparticles [28, 38], can be used to deliver genes and proteins to targets. Therefore, binding of immunostimulatory CpG ODN onto aminated MSNs will surely enhance the CpG ODN stability.…”
Section: Resultsmentioning
confidence: 99%
“…Studies demonstrated that nanoparticles, such as gold nanoparticles [15, 41, 42], silver nanoparticles [16], gelatin nanoparticles [43] and silica nanoparticles [28, 38], can be used to deliver genes and proteins to targets. Therefore, binding of immunostimulatory CpG ODN onto aminated MSNs will surely enhance the CpG ODN stability.…”
Section: Resultsmentioning
confidence: 99%
“…In addition, a nanoparticle based approach allows efficient antigen delivery to lymph nodes through lymphatic vessels in a size-dependent manner. Lee et al (46) reported gold nanoparticles (AuNP)-based cancer vaccines to increase immune response for toll-like receptor 9 (TLR-9) activation of DCs. Antigen delivery to lymph nodes can be tracked using computed tomography (CT) imaging.…”
Section: Multifunctional Nanoparticlesmentioning
confidence: 99%
“…Upon injection of the resulting 23 nm particles in the rear footpads of mice, their migration to the popliteal and inguinal nodes could be followed with CT scans [57] . To date however, not many research groups have reported on such multimodal particulate vaccines yet.…”
Section: Multifaceted Antigen-delivery Vehiclesmentioning
confidence: 99%